- Home
- MNDR vs AEON Comparison
MNDR vs AEON Comparison
Compare MNDR & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDR
- AEON
- Stock Information
- Founded
- MNDR 2016
- AEON N/A
- Country
- MNDR Singapore
- AEON United States
- Employees
- MNDR N/A
- AEON N/A
- Industry
- MNDR
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- MNDR
- AEON Health Care
- Exchange
- MNDR Nasdaq
- AEON Nasdaq
- Market Cap
- MNDR 6.8M
- AEON 8.0M
- IPO Year
- MNDR 2024
- AEON N/A
- Fundamental
- Price
- MNDR $1.07
- AEON $0.79
- Analyst Decision
- MNDR
- AEON Strong Buy
- Analyst Count
- MNDR 0
- AEON 1
- Target Price
- MNDR N/A
- AEON $360.00
- AVG Volume (30 Days)
- MNDR 74.1K
- AEON 153.4K
- Earning Date
- MNDR 06-16-2025
- AEON 08-11-2025
- Dividend Yield
- MNDR N/A
- AEON N/A
- EPS Growth
- MNDR N/A
- AEON N/A
- EPS
- MNDR N/A
- AEON 117.22
- Revenue
- MNDR $11,600,567.00
- AEON N/A
- Revenue This Year
- MNDR $188,831.77
- AEON N/A
- Revenue Next Year
- MNDR $76.44
- AEON N/A
- P/E Ratio
- MNDR N/A
- AEON $0.01
- Revenue Growth
- MNDR 0.61
- AEON N/A
- 52 Week Low
- MNDR $1.04
- AEON $0.38
- 52 Week High
- MNDR $9.52
- AEON $215.31
- Technical
- Relative Strength Index (RSI)
- MNDR N/A
- AEON 49.97
- Support Level
- MNDR N/A
- AEON $0.80
- Resistance Level
- MNDR N/A
- AEON $0.85
- Average True Range (ATR)
- MNDR 0.00
- AEON 0.05
- MACD
- MNDR 0.00
- AEON -0.01
- Stochastic Oscillator
- MNDR 0.00
- AEON 26.61
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.